share_log

Orthofix Medical Analyst Ratings

Benzinga ·  Jul 19, 2023 18:25
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
07/19/2023 30.75% BTIG → $27 Reinstates → Buy
03/04/2022 117.92% Stifel $41 → $45 Upgrades Hold → Buy
10/20/2020 88.86% Stifel → $39 Initiates Coverage On → Hold
02/25/2020 103.39% Cantor Fitzgerald $48 → $42 Maintains Neutral
02/25/2020 171.19% Sidoti & Co. $70 → $56 Maintains Buy
10/29/2019 132.45% Cantor Fitzgerald $71 → $48 Downgrades Overweight → Neutral
02/26/2019 BTIG Downgrades Buy → Neutral

What is the target price for Orthofix Medical (OFIX)?

The latest price target for Orthofix Medical (NASDAQ: OFIX) was reported by BTIG on July 19, 2023. The analyst firm set a price target for $27.00 expecting OFIX to rise to within 12 months (a possible 30.75% upside). 1 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Orthofix Medical (OFIX)?

The latest analyst rating for Orthofix Medical (NASDAQ: OFIX) was provided by BTIG, and Orthofix Medical their buy rating.

When is the next analyst rating going to be posted or updated for Orthofix Medical (OFIX)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Orthofix Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Orthofix Medical was filed on July 19, 2023 so you should expect the next rating to be made available sometime around July 19, 2024.

Is the Analyst Rating Orthofix Medical (OFIX) correct?

While ratings are subjective and will change, the latest Orthofix Medical (OFIX) rating was a with a price target of $0.00 to $27.00. The current price Orthofix Medical (OFIX) is trading at is $20.65, which is within the analyst's predicted range.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment